Monocyte tissue factor expression, cell activation, and thrombin formation during cardiopulmonary bypass: A clinical study
- 1 March 1997
- journal article
- clinical trial
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 113 (3), 576-584
- https://doi.org/10.1016/s0022-5223(97)70373-8
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Cell biology of tissue factor, the principal initiator of blood coagulationThrombosis Research, 1996
- Surface-bound heparin fails to reduce thrombin formation during clinical cardiopulmonary bypassThe Journal of Thoracic and Cardiovascular Surgery, 1996
- Hemostatic complications of cardiopulmonary bypassAmerican Journal of Hematology, 1995
- Role of factor XII in thrombin generation and fibrinolysis during cardiopulmonary bypassThe Lancet, 1994
- Heparin-coated cardiopulmonary bypass circuits: Hemostatic alterations and postoperative blood lossThe Annals of Thoracic Surgery, 1994
- Mechanisms of thrombin generation during surgery and cardiopulmonary bypass [see comments]Blood, 1993
- Heparin-coating of extracorporea circuits reduces thrombin formation in patients undergoing cardiopulmonary bypassPerfusion, 1991
- Alterations in coagulation and fibrinolysis associated with cardiopulmonary bypass during open heart surgeryJournal of Cardiothoracic Anesthesia, 1989
- Human neutrophil degranulation during extracorporeal circulationBlood, 1987
- A New Non-Thrombogenic Surface Prepared by Selective Covalent Binding of Heparin Via a Modified Reducing Terminal ResidueBiomaterials, Medical Devices, and Artificial Organs, 1983